X

About Us

Lorem ipsum dolor sit amet, consectetur elit, sed do eiusmod tempor incididunt ut labore et magna aliqua. Ut enim ad minim veniam laboris.

Get a free quote

Mon - Fri 8:00 - 6:30

Because everything affects our health, life, and legacy.

Join Today

News & Your Opinion

News & Your Opinion

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

On HALO

5 months ago

Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce certain risks associated with chronic kidney disease.

HALO NEWSLETTER

Join HALO today and unlock this story instantly — It's Free

SIGN UP LOGIN
5 months ago
On HALO

Opinion and Comments

LSU Tigers eliminate Arkansas, advance to CWS fina...

Wed, 07 25
On HALO

Alabama set to benefit from U.S. Steel’s $11 bil...

Wed, 07 25
On HALO

Longshore and McKnight: Both Auburn and Alabama se...

Wed, 07 25
On HALO